Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • ASNR Foundation Special Collection
    • Most Impactful AJNR Articles
    • Photon-Counting CT
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • ASNR Foundation Special Collection
    • Most Impactful AJNR Articles
    • Photon-Counting CT
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR is seeking candidates for the AJNR Podcast Editor. Read the position description.

OtherBRAIN

Spin-Echo Echo-Planar Perfusion MR Imaging in the Differential Diagnosis of Solitary Enhancing Brain Lesions: Distinguishing Solitary Metastases from Primary Glioma

G.S. Young and K. Setayesh
American Journal of Neuroradiology March 2009, 30 (3) 575-577; DOI: https://doi.org/10.3174/ajnr.A1239
G.S. Young
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Setayesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

SUMMARY: Unlike the more widely reported gradient-echo echo-planar perfusion-weighted imaging (EPI-PWI) technique, spin-echo (SE) EPI relative cerebral blood volume maps select for blood volume in microvessels <8 μm in diameter. This first report of SE-EPI PWI for distinguishing brain metastasis from high-grade glioma demonstrated 88% sensitivity and 72% specificity in 83 patients. We discuss differences in microvessel architecture between high-grade glioma and brain metastasis that may explain the surprising success of SE-EPI in this application and may deserve further investigation.

Distinction of brain metastasis from high-grade glioma by MR imaging remains an important unsolved clinical problem. Percentage recovery analysis of time-intensity curves from gradient-echo echo-planar (GE-EPI) dynamic susceptibility contrast perfusion-weighted imaging (PWI)1 has been proposed to distinguish these tumor types by assessing increased capillary permeability in brain metastasis, but to our knowledge, no published report yet documents the accuracy of this method. Reports from the pathology literature suggest that in addition to permeability, brain metastasis and high-grade glioma neovessels differ substantially in vascular architecture,2–7 and in particular, metastases may contain a substantially larger proportion of intermediate-sized dysplastic vessels up to 70 μm in diameter.8–12 Recent literature demonstrates that spin-echo EPI (SE-EPI) PWI has a substantially different vessel-size sensitivity profile from GE-EPI PWI.13–15 Because SE-EPI PWI relative cerebral blood volume (rCBV) maps reflect nearly exclusively the blood volume of microvessels <8 μm in diameter, in contrast to the admixture of microvessels and larger vessels assessed with GE-EPI, we hypothesized that SE-EPI rCBV maps would allow reliable distinction of brain metastasis from high-grade glioma. To our knowledge, this is the first report using SE-EPI PWI to make this distinction.

Technique

Forty-three subjects with high-grade glioma (20 cases of glioblastoma multiforme, 14 anaplastic astrocytomas, 7 anaplastic oligoastrocytomas, and 2 unspecified high-grade gliomas) and 40 patients with brain metastasis (2 sarcomas; 38 carcinomas, including 20 lung, 5 melanoma, 1 basal cell, 4 breast, 1 esophageal, 2 colorectal, 1 prostate; and 4 adenocarcinomas of unknown primary) were included chronologically from our institutional data base. Ninety-eight percent (42) of patients with high-grade glioma and 68% (27) of patients with brain metastasis had received previous chemotherapy; 63% (27) of patients with high-grade glioma and 85% of patients with metastasis (34) had received radiation (Table 1). Following institutional protocol, SE-EPI PWI (TE = 80 ms, TR = 1900–2216.7 ms, section thickness = 10 mm, matrix = 1282–2562) was performed by using a 4-mL/s bolus injection of 30-mL double-dose gadopentetate dimeglumine (Magnevist; Bayer HealthCare Pharmaceuticals, Wayne, NJ) (0.15–0.3 mmol/kg depending on body weight) and was coregistered with delayed postgadolinium T1-weighted imaging. Imaging was performed on 1.5T or 3T commercial MR imaging scanners (GE Healthcare, Milwaukee, Wis), and PWI data were processed by using a perfusion-processing software package (GADW 4.3 FuncTool software, GE Healthcare), which creates color rCBV maps by calculating the change in transverse relaxivity (R2) from signal-intensity measurements, integrates the area under the relaxivity curve and corrects for TE, according to the following standard formula: Math

View this table:
  • View inline
  • View popup
Table 1:

Patient Demographics

Following previously published “hot spot” methods, we selected a roughly 100-mm2 region of interest (ROI) within the region of maximal rCBV and recorded the average rCBV within the ROI as the rCBVmax.16,17 We calculated a normalized rCBV (nCBV) by dividing rCBVmax by the rCBV of an equivalent ROI in the contralateral normal-appearing white matter16 and performed percentage recovery analysis in the same ROI according to previously reported GE-EPI techniques.1

Results

The average nCBV within enhancing high-grade glioma was 1.53 ± 0.79 (0.59–4.05) compared with 0.82 ± 0.40 for brain metastasis (0.48–2.12), and differences between nCBV averages and ranges for the 2 groups were significant (P < .05) (Fig 1C). Sensitivity and specificity for detection of brain metastasis were 95% and 51%, respectively, by using an nCBV threshold of 1.3; and 36% and 93%, by using a 0.7 threshold. The optimal threshold occurred at 1.0, where sensitivity and specificity were 88% and 72% (Table 2).

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

A and B, rCBV maps (left) demonstrate increased blood volume in the enhancing high-grade glioma (A) and decreased blood volume in the enhancing brain metastasis (B). Corresponding T1-weighted images are shown (center) with black arrows representing the location of ROI selection in the lesion and white arrows indicating control ROI location in normal appearing contralateral white matter placement. C, Scatterplot of the nCBV measurements in brain metastasis (blue diamonds) and high-grade glioma (red squares). (Color figure is available on-line only at www.ajnr.org.)

View this table:
  • View inline
  • View popup
Table 2:

Diagnostic Accuracy of SE-EPI nCBV vs. Percent Recovery Using Optimal Thresholds of nCBV = 1.0 and % recovery = 66%

Percentage recovery analysis yielded average signal-intensity recoveries of 0.86 for high-grade glioma and 0.75 for brain metastasis (P < .05). Percentage recovery analysis sensitivity and specificity to distinguish brain metastasis from high-grade glioma were 18% and 93% by using a previously reported1 signal-intensity recovery threshold of 0.66. Optimal accuracy, obtained by using a signal-intensity recovery threshold of 0.85, yielded a sensitivity and specificity of 84% and 48% (Table 2).

Discussion

In this retrospective series, SE-EPI-derived rCBV maps allowed reliable distinction of brain metastasis from high-grade glioma and were superior to percentage recovery analysis for distinguishing brain metastasis from high-grade glioma by using SE-EPI (Fig 1). Because of the limitations regarding the retrospective design of this initial report, further study is required before this finding can be applied clinically. Most important, although both groups received radiation and chemotherapy, differences in treatment response between the groups could conceivably contribute to the differences observed.

Although definitive testing of our hypothesis that the success of SE-EPI is related to differences in vessel-size distribution between brain metastasis and high-grade glioma is beyond the scope of this report, a number of limitations of the current data deserve consideration in the design of future studies. First, as our percentage recovery analysis demonstrates, there is a significant difference between the brain metastasis and high-grade glioma groups in microvessel permeability. Future studies designed to investigate whether the observed effect is actually related to vessel-size differences between brain metastasis and high-grade glioma will require more rigorous correction for T1 shortening effects due to first-pass capillary leak.18 Additionally, the use of interleaved GE-SE vessel-size imaging5,6 may be of interest. Finally, because of the paucity of direct analyses of metastatic vessel-size distribution in the pathology literature, correlation with microscopic imaging would be valuable.

Conclusion

SE-EPI-derived rCBV maps promise to assist in accurate preoperative distinction of brain metastasis from high-grade glioma. If more rigorous analysis in treatment-naïve patients and prospective investigation support the preliminary findings presented here, SE-EPI PWI may prove an important clinical tool.

Footnotes

  • Both authors contributed equally to this work.

References

  1. ↵
    Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 2003;49:848–55
    CrossRefPubMed
  2. ↵
    Deane BR, Lantos PL. The vasculature of experimental brain tumors. Part 1. A sequential light and electron microscope study of angiogenesis J Neurol Sci 1981;49:55–66
    CrossRefPubMed
  3. Dennie J, Mandeville JB, Boxerman JL, et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40:793–99
    PubMed
  4. Kremer S, Grand S, Berger F, et al. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 2003;45:44–49
    PubMed
  5. ↵
    Kiselev VG, Strecker R, Ziyeh S, et al. Vessel size imaging in humans. Magn Reson Med 2005;53:553–63
    CrossRefPubMed
  6. ↵
    Tropres I, Grimault S, Vaeth A, et al. Vessel size imaging. Magn Reson Med 2001;45:397–408
    CrossRefPubMed
  7. ↵
    Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51
    PubMed
  8. ↵
    Nussbaum E, Djalilian H, Cho K, et al. Brain metastases: histology, multiplicity, surgery, and survival. Cancer 1996;78:1781–88
    CrossRefPubMed
  9. Lu W, Bucana CD, Schroit AJ. Pathogenesis and vascular integrity of breast cancer brain metastasis. Int J Cancer 2007;120:1023–26
    CrossRefPubMed
  10. Onodera H, Nagayama S, Tachibana T, et al. Brain metastasis from colorectal cancer. Int J Colorectal Dis 2005;20:57–61
    CrossRefPubMed
  11. McCurley CR, Shivers RR, Del Maestro RF. Quantitative comparison of the morphology of the microvasculature of primary lung lesions and metastatic brain tumors. J Submicrosc Cytol Pathol 1998;30:257–69
    PubMed
  12. ↵
    Sangiorgi S, Congiu T, Manelli A, et al. The three-dimensional microvascular architecture of the human Kaposi sarcoma implanted in nude mice: A SEM corrosion casting study. Microvasc Res 2006;72:128–35. Epub 2006 Aug 22
    CrossRefPubMed
  13. ↵
    Donahue KM, Krouwer HGJ, Rand SD, et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000;43:845–53
    CrossRefPubMed
  14. Sugahara T, Korogi Y, Kochi M, et al. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR Am J Neuroradiol 2001;22:1306–15
    Abstract/FREE Full Text
  15. ↵
    Speck O, Chang L, DeSilva NM, et al. Perfusion MRI of the human brain with dynamic susceptibility contrast: gradient-echo versus spin-echo techniques. J Magn Reson Imaging 2000;12:381–87
    CrossRefPubMed
  16. ↵
    Calli C, Kitis O, Yunten N, et al. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394–403
    CrossRefPubMed
  17. ↵
    Cha S, Tihan T, Crawford F, et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005;26:266–73
    Abstract/FREE Full Text
  18. ↵
    Boxerman JL, Schmainda KM, Weiskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859–67
    Abstract/FREE Full Text
  • Received April 10, 2008.
  • Accepted after revision June 5, 2008.
  • Copyright © American Society of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 30 (3)
American Journal of Neuroradiology
Vol. 30, Issue 3
March 2009
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Spin-Echo Echo-Planar Perfusion MR Imaging in the Differential Diagnosis of Solitary Enhancing Brain Lesions: Distinguishing Solitary Metastases from Primary Glioma
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
G.S. Young, K. Setayesh
Spin-Echo Echo-Planar Perfusion MR Imaging in the Differential Diagnosis of Solitary Enhancing Brain Lesions: Distinguishing Solitary Metastases from Primary Glioma
American Journal of Neuroradiology Mar 2009, 30 (3) 575-577; DOI: 10.3174/ajnr.A1239

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Spin-Echo Echo-Planar Perfusion MR Imaging in the Differential Diagnosis of Solitary Enhancing Brain Lesions: Distinguishing Solitary Metastases from Primary Glioma
G.S. Young, K. Setayesh
American Journal of Neuroradiology Mar 2009, 30 (3) 575-577; DOI: 10.3174/ajnr.A1239
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Technique
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Solitary Cerebral Metastases vs. High-grade Gliomas: Usefulness of Two MRI Signs in the Differential Diagnosis
  • Differentiation of Low- and High-Grade Gliomas Using High b-Value Diffusion Imaging with a Non-Gaussian Diffusion Model
  • Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma
  • Differentiation between Brain Glioblastoma Multiforme and Solitary Metastasis: Qualitative and Quantitative Analysis Based on Routine MR Imaging
  • Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
  • Crossref (33)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI
    Yong Hwy Kim, So Won Oh, You Jung Lim, Chul-Kee Park, Se-Hoon Lee, Keon Wook Kang, Hee-Won Jung, Kee Hyun Chang
    Clinical Neurology and Neurosurgery 2010 112 9
  • Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
    L.S. Hu, J.M. Eschbacher, A.C. Dueck, J.E. Heiserman, S. Liu, J.P. Karis, K.A. Smith, W.R. Shapiro, D.S. Pinnaduwage, S.W. Coons, P. Nakaji, J. Debbins, B.G. Feuerstein, L.C. Baxter
    American Journal of Neuroradiology 2012 33 1
  • Differentiation of Low- and High-Grade Pediatric Brain Tumors with Highb-Value Diffusion-weighted MR Imaging and a Fractional Order Calculus Model
    Yi Sui, He Wang, Guanzhong Liu, Frederick W. Damen, Christian Wanamaker, Yuhua Li, Xiaohong Joe Zhou
    Radiology 2015 277 2
  • Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis
    Andrés Server, Tone E. Døli Orheim, Bjørn A. Graff, Roger Josefsen, Theresa Kumar, Per H. Nakstad
    Neuroradiology 2011 53 5
  • Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI
    B. Hakyemez, C. Erdogan, G. Gokalp, A. Dusak, M. Parlak
    Clinical Radiology 2010 65 1
  • Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas
    Stella Blasel, Alina Jurcoane, Kea Franz, Gerald Morawe, Stefanie Pellikan, Elke Hattingen
    Acta Neurochirurgica 2010 152 11
  • Gradient of Apparent Diffusion Coefficient Values in Peritumoral Edema Helps in Differentiation of Glioblastoma From Solitary Metastatic Lesions
    Pierre Lemercier, Silvia Paz Maya, James T. Patrie, Lucía Flors, Carlos Leiva-Salinas
    American Journal of Roentgenology 2014 203 1
  • Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma
    L.S. Hu, Z. Kelm, P. Korfiatis, A.C. Dueck, C. Elrod, B.M. Ellingson, T.J. Kaufmann, J.M. Eschbacher, J.P. Karis, K. Smith, P. Nakaji, D. Brinkman, D. Pafundi, L.C. Baxter, B.J. Erickson
    American Journal of Neuroradiology 2015 36 12
  • Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis
    Chong Hyun Suh, Ho Sung Kim, Seung Chai Jung, Choong Gon Choi, Sang Joon Kim
    European Radiology 2018 28 9
  • Brain Tumors
    Lara A. Brandão, Mark S. Shiroishi, Meng Law
    Magnetic Resonance Imaging Clinics of North America 2013 21 2

More in this TOC Section

  • Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease
  • White Matter Alterations in the Brains of Patients with Active, Remitted, and Cured Cushing Syndrome: A DTI Study
  • Qualitative and Quantitative Analysis of MR Imaging Findings in Patients with Middle Cerebral Artery Stroke Implanted with Mesenchymal Stem Cells
Show more BRAIN

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • AJNR Awards
  • ASNR Foundation Special Collection
  • Most Impactful AJNR Articles
  • Photon-Counting CT
  • Spinal CSF Leak Articles (Jan 2020-June 2024)

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire